This inventor holds 4 USPTO granted patents and 2 EPO patents. Top assignee: Novartis Ag. Active years: 2017-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017-2020
Title: **The Innovative Journey of Luciana Ferrara in Pharmaceutical Research**
Introduction
Luciana Ferrara is a noteworthy inventor based in Stoughton, MA, known for her significant contributions to pharmaceutical research. With a total of four patents under her name, her work primarily focuses on the development of compounds that serve as soluble guanylate cyclase activators, which have important therapeutic applications.
Latest Patents
Among her latest patents, Luciana has developed indane and indoline derivatives that are essential as soluble guanylate cyclase activators. The present invention provides a compound of formula (I), or a pharmaceutically acceptable salt thereof, along with methods for manufacturing these compounds and their therapeutic uses. Moreover, the invention also details a combination of pharmacologically active agents and a pharmaceutical composition, showcasing the depth of innovation in her research.
Career Highlights
Luciana works at Novartis AG, a leading global healthcare company. Her innovative research in medicinal chemistry has led to groundbreaking discoveries that aim to enhance therapeutic outcomes for patients. With her expertise, she continues to drive advancements in drug development, focusing on improving health interventions.
Collaborations
In her professional journey, Luciana has collaborated with several esteemed colleagues, including Christopher Michael Adams and Doug Bevan. These collaborations have fostered an environment of innovation and creativity, allowing for the exchange of ideas that informs her research and enhances the quality of her inventions.
Conclusion
Luciana Ferrara exemplifies the spirit of innovation in the pharmaceutical field. With her valuable contributions and a strong foundation in research, she remains a key figure in the development of novel therapeutic agents. Her work not only propels forward the boundaries of science but also has the potential to significantly impact patient care and the healthcare industry as a whole.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile